Researcher
Diederik De Cock
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Nov 2021 → 31 May 2022 - Skeletal Biology and Engineering Research Center (Division)
Member
From1 Apr 2013 → 31 Oct 2021
Projects
1 - 1 of 1
- The Future of Early Rheumatoid Arthritis Management: From Disease Control to Patient WellbeingFrom1 Oct 2018 → 31 Oct 2021Funding: FWO fellowships
Publications
21 - 30 of 76
- Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT(2020)
Authors: Veerle Stouten, Rene Westhovens, Diederik De Cock, Patrick Verschueren
Pages: 2593 - 2601 - ANALGESIC AND ANTI-INFLAMMATORY DRUG USE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND SPONDYLOARTHRITIS VERSUS CONTROLS IN A BELGIAN GENERAL PRACTITIONER REGISTRY.(2020)
Authors: S Pazmino, Veerle Stouten, P Verschueren, Pavlos Mamouris, R Westhovens, K De Vlam, D Bertrand, K Van der Elst, B Vaes, Diederik De Cock
Pages: 1863 - 1863 - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update(2020)
Authors: Diederik De Cock, Rene Westhovens
Pages: 685 - 699 - CLINICAL TREATMENT RESPONSE STILL DOES NOT MATCH PATIENT REPORTED IMPROVEMENT, EVEN IN EARLY RHEUMATOID ARTHRITIS(2020)
Authors: S Pazmino, A Lovik, A Boonen, Diederik De Cock, Veerle Stouten, J Joly, D Bertrand, R Westhovens, P Verschueren
Pages: 578 - 578 - The rheumatoid arthritis patient global assessment: improve it or lose it!(2020)
Authors: Diederik De Cock
Pages: 923 - 924 - Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial(2020)
Authors: Veerle Stouten, Diederik De Cock, Rene Westhovens, Patrick Verschueren
- Response to Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center.(2020)
Authors: Diederik De Cock, Eliane Vanhoffelen, Veerle Stouten, Patrick Verschueren, Rene Westhovens
Pages: e6 - One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor wellbeing after one year of treatment(2020)
Authors: Patrick Verschueren, Diederik De Cock, An De Groef, Veerle Stouten, Philip Moons, Rene Westhovens
- Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA(2019)
Authors: Veerle Stouten, Rene Westhovens, Diederik De Cock, Kristien Van der Elst, Patrick Verschueren, Kurt De Vlam
Pages: 2284 - 2294 - Patient-Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target(2019)
Authors: Kristien Van der Elst, Patrick Verschueren, Veerle Stouten, An De Groef, Diederik De Cock, Philip Moons, Rene Westhovens
Pages: 1566 - 1575